IRVINE, Calif.--(BUSINESS WIRE)--July 27, 2006--Endologix, Inc. (Nasdaq:ELGX - News), developer and manufacturer of the Powerlink® System endoluminal stent graft (ELG) for the minimally invasive treatment of abdominal aortic aneurysms (AAA), today announced financial results for the three months and six months ended June 30, 2006.
